Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.53 |
| ▸ | LPL | P06858 | 8/20 | 0.53 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | XRCC6 | P12956 | 1/20 | 0.32 |
| ▸ | XRCC5 | P13010 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22146995 | 0.89 | LIPG (0.40) | LIPGLPLCSF1RPGRPIK3CD | |
| SCHEMBL22073877 | 0.83 | LPL (0.39) | LIPGLPLPGRPIK3CDXRCC6 | |
| SCHEMBL22161117 | 0.81 | LIPG (0.52) | LIPGLPLCSF1RIRAK4GPR84 | |
| SCHEMBL21146839 | 0.81 | LPL (0.46) | LIPGLPLCSF1RPGRIRAK4 | |
| SCHEMBL13098741 | 0.81 | LIPG (0.71) | LIPGLPLSNCADGAT1IRAK4 | |
| SCHEMBL22161118 | 0.81 | LIPG (0.60) | LIPGLPLCSF1RPGRSNCA | |
| SCHEMBL22161106 | 0.81 | LIPG (0.60) | LIPGLPLCSF1RPGRSNCA | |
| SCHEMBL10122594 | 0.79 | GPR84 (0.41) | PIK3CDXRCC6XRCC5PRKDCAHR | |
| SCHEMBL22697850 | 0.79 | LIPG (0.61) | LIPGLPLCSF1RPGRSNCA | |
| SCHEMBL22087251 | 0.79 | LIPG (0.54) | LIPGLPLCSF1RPGRIRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-06-21 | — | — | US | disclosed |
| US-20220029104-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-20200203623-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
| EP-3670510-A2 | BENZO[B]NAPHTHO[2,3-D]FURANYL- OR BENZO[B]NAPHTHO[2,3-D]THIOPHENYL-TRIAZINE COMPOUNDS FOR ORGANIC ELECTRONIC ELEMENTS | Duk San Neolux Co., Ltd. (KR) | 2020-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | ORAI2, KCNJ2, OR10J3 | LIPG 760/4885LPL 2557/4885CSF1R 4566/4885 |
| US-20200203623-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | GPX1, PIEZO1, ORAI2 | LIPG 1584/4885LPL 3799/4885CSF1R 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.